Recently Viewed

Clear All

News & Announcements - Nath Bio-Genes

Nath Bio-Genes : Latest updates and developments

Announcement under Regulation 30 (LODR)-Investor Presentation

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Outcome Of Board Meeting

Board Meeting Intimation for Approval Of Financial Results As On 31St December 2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

Closure of Trading Window

Top Picks

'25 funds in my portfolio. Where do I even begin?'

5 min read•By Udhayaprakash

The only way to actually lose money on your SIP

12 min read•By Pranit Mathur

The problem with your emergency fund

4 min read•By Ameya Satyawadi

War, Wealth & What To Do

9 min read•By Value Research down-arrow-icon

How to get fixed income right for your retirement?

3 min read•By Ameya Satyawadi

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Announcement under Regulation 30 (LODR)-Investor Presentation

Financial Results As On 30Th September 2025

Board Meeting Outcome for Outcome Of Board Meeting

Intimation Of Earning Conference Call

Board Meeting Intimation for Approval Of Financial Results As On 30Th Sept 2025

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Explore Other Categories

See All Categories
Load more down-arrow-icon
{__(loading...)}
ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Speciality Medicines 117 - 124 20-Mar-2026 to 24-Mar-2026
Central Mine Planning & Design Institute 163 - 172 20-Mar-2026 to 24-Mar-2026
Highness Microelectronics 114 - 120 24-Mar-2026 to 27-Mar-2026
Amir Chand Jagdish Kumar (Exports) 201 - 212 24-Mar-2026 to 27-Mar-2026
IPO MonitorIPO Monitor